Citation Impact
Citing Papers
Testosterone and Dihydrotestosterone Tissue Levels in Recurrent Prostate Cancer
2005
Androgen Levels Increase by Intratumoral De novo Steroidogenesis during Progression of Castration-Resistant Prostate Cancer
2008
The American Urological Association Symptom Index for Benign Prostatic Hyperplasia
1992 Standout
High Prevalence of Vitamin D Inadequacy and Implications for Health
2006 Standout
Review of the role of androgenic hormones in the epidemiology of benign prostatc hyperplasia and prostate cancer
1994
Increased Survival with Enzalutamide in Prostate Cancer after Chemotherapy
2012 Standout
Natural History of Progression After PSA Elevation Following Radical Prostatectomy
1999 Standout
Sunlight and Vitamin D
2013 Standout
Effects of Muscle Strength Training and Megestrol Acetate on Strength, Muscle Mass, and Function in Frail Older People
2006
Towards Engineering Hormone-Binding Globulins as Drug Delivery Agents
2014
Chemotherapy with mitoxantrone plus prednisone or prednisone alone for symptomatic hormone-resistant prostate cancer: a Canadian randomized trial with palliative end points.
1996 Standout
Cancer Cell Metabolism: Warburg and Beyond
2008 Standout
Noninvasive Detection of Clinically Occult Lymph-Node Metastases in Prostate Cancer
2003 Standout
Epidemiology of Prostate Cancer
2019 Standout
A Controlled Trial of Leuprolide with and without Flutamide in Prostatic Carcinoma
1989
Estimation of optimal serum concentrations of 25-hydroxyvitamin D for multiple health outcomes
2006 Standout
Flutamide withdrawal syndrome: its impact on clinical trials in hormone-refractory prostate cancer.
1993
Mechanisms involved in the progression of androgen-independent prostate cancers: it is not only the cancer cell's fault.
2002
The development of androgen-independent prostate cancer
2001 Standout
Insulin and insulin-like growth factor signalling in neoplasia
2008 Standout
Cancer-associated cachexia
2018 Standout
Docetaxel plus Prednisone or Mitoxantrone plus Prednisone for Advanced Prostate Cancer
2004 Standout
Outsmarting androgen receptor: creative approaches for targeting aberrant androgen signaling in advanced prostate cancer
2011
Management of benign prostatic hyperplasia with particular emphasis on aromatase inhibitors
1993
Effects of Testosterone Replacement and/or Resistance Exercise on the Composition of Megestrol Acetate Stimulated Weight Gain in Elderly Men: A Randomized Controlled Trial
2002
Medical outcomes research and benign prostatic hyperplasia
1990
Androgen action and metabolism in prostate cancer
2012
Age Trends in the Level of Serum Testosterone and Other Hormones in Middle-Aged Men: Longitudinal Results from the Massachusetts Male Aging Study
2002 Standout
Hormone and antihormone withdrawal: implications for the management of androgen-independent prostate cancer
1996
Treatment of metastatic prostatic cancer with low-dose prednisone: evaluation of pain and quality of life as pragmatic indices of response.
1989
Sipuleucel-T Immunotherapy for Castration-Resistant Prostate Cancer
2010 Standout
The American Urological Association Symptom Index for Benign Prostatic Hyperplasia
2016 Standout
Docetaxel and Estramustine Compared with Mitoxantrone and Prednisone for Advanced Refractory Prostate Cancer
2004 Standout
Chemohormonal Therapy in Metastatic Hormone-Sensitive Prostate Cancer
2015 Standout
Bilateral Orchiectomy with or without Flutamide for Metastatic Prostate Cancer
1998
HOW IS ANDROGEN-DEPENDENT METASTATIC PROSTATE CANCER BEST TREATED?
1996
Targeting the androgen receptor: improving outcomes for castration-resistant prostate cancer
2004
Interaction of male and female sex hormones in cultured rat prostate
1987
Anemia After Orchiectomy
1998
Adverse Effects of Androgen Deprivation Therapy and Strategies to Mitigate Them
2014 Standout
Abiraterone plus Prednisone in Metastatic, Castration-Sensitive Prostate Cancer
2017 Standout
Treatment of Prostate Cancer with Gonadotropin-Releasing Hormone Agonists
1986
Vitamin D and breast cancer risk: the NHANES I Epidemiologic follow-up study, 1971-1975 to 1992. National Health and Nutrition Examination Survey.
1999
Endocrine Therapy of Breast and Prostate Cancer
1989
Celastrol, a Triterpene Extracted from the Chinese “Thunder of God Vine,” Is a Potent Proteasome Inhibitor and Suppresses Human Prostate Cancer Growth in Nude Mice
2006 Standout
EDC-2: The Endocrine Society's Second Scientific Statement on Endocrine-Disrupting Chemicals
2015 Standout
Increased Expression of Genes Converting Adrenal Androgens to Testosterone in Androgen-Independent Prostate Cancer
2006 Standout
Nonoperative Management of Benign Prostatic Hyperplasia
1989
Epidemiology and Natural History of Benign Prostatic Hyperplasia
1990
Effects of Estrogens Only on the Prostates of Aging Men
1996
Symptom Status and Quality of Life Following Prostatectomy
1988
Systemic Complications of Acromegaly: Epidemiology, Pathogenesis, and Management
2004 Standout
A prospective, population-based study of androstenedione, estrogens, and prostatic cancer.
1990
An Antibody Targeting the Type I Insulin-like Growth Factor Receptor Enhances the Castration-Induced Response in Androgen-Dependent Prostate Cancer
2007
Cloning of a novel receptor expressed in rat prostate and ovary.
1996 Standout
Mechanisms of Estrogen Action
2001 Standout
Metastatic bone disease: clinical features, pathophysiology and treatment strategies
2001 Standout
A Critical Appraisal of the Quality of Quality-of-Life Measurements
1994 Standout
The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection.
1992 Standout
The Role of Vitamin D in Cancer Prevention
2005 Standout
Clinical Features of Metastatic Bone Disease and Risk of Skeletal Morbidity
2006 Standout
Control over overall shape and size in de novo designed proteins
2015 StandoutNobel
The pathogenesis of benign prostatic hyperplasia
1980 Standout
Progressive resistance strength training for improving physical function in older adults
2009 Standout
ANDROGEN RECEPTOR GENE AMPLIFICATION AT PRIMARY PROGRESSION PREDICTS RESPONSE TO COMBINED ANDROGEN BLOCKADE AS SECOND LINE THERAPY FOR ADVANCED PROSTATE CANCER
2000
Endocrine Treatment of Gender-Dysphoric/Gender-Incongruent Persons: An Endocrine Society* Clinical Practice Guideline
2017 Standout
Skeletal complications of malignancy
1997 Standout
Design and End Points of Clinical Trials for Patients With Progressive Prostate Cancer and Castrate Levels of Testosterone: Recommendations of the Prostate Cancer Clinical Trials Working Group
2008 Standout
The Androgen Axis in Recurrent Prostate Cancer
2004
Endocrine dependence of prostatic cancer upon dihydrotestosterone and not upon testosterone
1984
Works of Jerry Albert being referenced
Comparison of Prostatic Cancer Tissue Dihydrotestosterone Levels at the Time of Relapse Following Orchiectomy or Estrogen Therapy
1984
DHT in prostate cancer tissue— a guide to management and therapy
1985
Tissue Dihydrotestosterone Levels and Clinical Response to Hormonal Therapy in Patients with Advanced Prostate Cancer*
1984
A method for tissue extraction and determination of prostate concentrations of endogenous androgens by radioimmunoassay
1976
Acute therapy with megestrol acetate decreases nuclear and cytosol androgen receptors in human BPH tissue
1982
Medical Castration of Males with Megestrol Acetate and Small Doses of Diethylstilbestrol*
1981
Adrenal androgen blockade in relapsed prostate cancer
1985
Prostate concentrations of endogenous androgens by radioimmunoassay
1976
Advantages of total androgen blockade in the treatment of advanced prostate cancer.
1988
Effect of Tamoxifen on Stromal Protein Synthesis in the Human Prostate*
1984
Treatment of advanced cancer of prostate with megestrol acetate
1978
Effect of antiandrogen and/or antiestrogen blockade on human prostate epithelial and stromal cell protein synthesis
1986
Effect of megestrol acetate on uroflow rates in patients with benign prostatic hypertrophy
1979
Effect of Megestrol Acetate (Megace®) on Steroid Metabolism and Steroid-Protein Binding in the Human Prostate
1976
Acute Effects of Testicular and Adrenal Cortical Blockade on Protein Synthesis and Dihydrotestosterone Content of Human Prostate Tissue*
1985
Steroid levels in cancer of the prostate-markers of tumour differentiation and adequacy of anti-androgen therapy
1979